Tagged: olo

March 18, 2020 @ 9:00 am By JD Alois  |  

Sight Diagnostics, an OurCrowd portfolio company, is helping to lead the response to the Coronavirus pandemic. Sight’s OLO, a compact blood analyzer that can provide rapid, lab-grade CBC [complete blood count] results, has been installed in Sheba Tel Hashomer’s (Israel’s largest hospital that is supported… Read More

December 4, 2019 @ 12:34 pm By JD Alois  |  

We all know the story of Elizabeth Holmes and the demise of Theranos, a company that claimed to have created a device that could provide fast and efficient blood tests. Theranos ended being a company based on hubris, imagination, and vapor. It eventually collapsed being… Read More

February 18, 2019 @ 1:06 am By JD Alois  |  

OurCrowd has joined in the Series C funding of Medtech firm Sight Diagnostics. The company is creating a lab-grade point-of-care blood diagnostics system “OLO.” This system is designed to provide patients with lab-grade blood testing results in minutes rather than days by combining AI with… Read More